BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 32222826)

  • 1. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities.
    Vesterhus M; Karlsen TH
    J Gastroenterol; 2020 Jun; 55(6):588-614. PubMed ID: 32222826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent insights in primary sclerosing cholangitis.
    Ponsioen CY
    J Dig Dis; 2012 Jul; 13(7):337-41. PubMed ID: 22713082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    Smith T; Befeler AS
    Curr Gastroenterol Rep; 2007 Mar; 9(1):54-9. PubMed ID: 17335678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
    Eaton JE; Talwalkar JA; Lazaridis KN; Gores GJ; Lindor KD
    Gastroenterology; 2013 Sep; 145(3):521-36. PubMed ID: 23827861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary sclerosing cholangitis.
    Silveira MG; Lindor KD
    Can J Gastroenterol; 2008 Aug; 22(8):689-98. PubMed ID: 18701947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of primary sclerosing cholangitis.
    Floreani A; De Martin S
    Dig Liver Dis; 2021 Dec; 53(12):1531-1538. PubMed ID: 34011480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.
    Zhu GQ; Shi KQ; Huang GQ; Wang LR; Lin YQ; Braddock M; Chen YP; Zhou MT; Zheng MH
    Oncotarget; 2015 Sep; 6(29):26757-69. PubMed ID: 26378046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
    Franco J; Saeian K
    Curr Gastroenterol Rep; 1999 Apr; 1(2):95-101. PubMed ID: 10980934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medical management of primary sclerosing cholangitis.
    Michaels A; Levy C
    Medscape J Med; 2008 Mar; 10(3):61. PubMed ID: 18449341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
    Triantos CK; Koukias NM; Nikolopoulou VN; Burroughs AK
    Aliment Pharmacol Ther; 2011 Oct; 34(8):901-10. PubMed ID: 21883323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary sclerosing cholangitis.
    Zein CO; Lindor KD
    Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerosing cholangitis.
    MacFaul GR; Chapman RW
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
    Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A
    Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
    Ahn DW
    Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for primary sclerosing cholangitis.
    Sinakos E; Lindor K
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):473-88. PubMed ID: 20678020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis.
    Karlsen TH; Vesterhus M; Boberg KM
    Aliment Pharmacol Ther; 2014 Feb; 39(3):282-301. PubMed ID: 24372568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary sclerosing cholangitis : Current diagnostics and treatment].
    Liwinski T; Schramm C
    Internist (Berl); 2018 Jun; 59(6):551-559. PubMed ID: 29700559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapies and clinical controversies in the management of primary sclerosing cholangitis.
    Prall RT; Lindor KD; Wiesner RH; LaRusso NF
    Curr Gastroenterol Rep; 2000 Apr; 2(2):99-103. PubMed ID: 10981010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.
    Sinakos E; Marschall HU; Kowdley KV; Befeler A; Keach J; Lindor K
    Hepatology; 2010 Jul; 52(1):197-203. PubMed ID: 20564380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary sclerosing cholangitis: diagnosis, prognosis, and management.
    Singh S; Talwalkar JA
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):898-907. PubMed ID: 23454027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.